Azafaros B.V., a clinical-stage biotechnology company focused on rare diseases and lysosomal storage disorders, today announced that advancements with its lead asset, nizubaglustat, will feature ...

The 2024 Interdisciplinary Biomedical Research Symposium was held Saturday, Nov. 16, at A.T. Still University in ...

Additionally, five poster presentations (one being a collaboration with patient ... “We are honoured to present our research ...

TruSight Oncology portfolio enables clinical research and in-vitro diagnostic CGP solutions ...

Title: ALG-055009, a Novel Thyroid Hormone Receptor Beta (THR-β) Agonist, was Well-tolerated with Significant Reductions in ...

vice president for research and development at Eradivir, presented information on two Eradivir drug compounds during OPTIONS ...

Qatar University (QU)'s College of Engineering will organise the Fourth World Congress on Engineering and Technology from Dec ...

Eradivir , a preclinical biotech company, has developed a patent-pending antiviral therapeutic that reduces lung viral loads ...

Nektar Therapeutics Presents First Preclinical Data from Novel CSF-1 Program, NKTR-422, at 2024 American College of Rheumatology (ACR) Convergence ...

The firm's co-founder and director on the success of his Create More podcast, the importance of having fun and why it is ...

Detailed price information for Seastar Medical Hldg Corp (ICU-Q) from The Globe and Mail including charting and trades.

Have the traditions of science—rituals of poster presentations and tenure positions—evolved ... Their discussion did pass the test of science: Phillips and her colleagues' research was recently ...